Active, Not Recruiting
Savolitinib vs. Sunitinib in MET-driven PRCC.
NCT03091192
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Research Site La Jolla, California, United States
- Research Site Atlanta, Georgia, United States
- Research Site Chicago, Illinois, United States
- Research Site Iowa City, Iowa, United States